Review showing the utility of Adalimumab (monoclonal antibody anti-TNF) in management of immune-mediated inflammatory diseases
Adalimumab in the treatment of immune-mediated diseases / Lapadula G, Marchesoni A, Armuzzi A, Blandizzi C, Caporali R, Chimenti S, Cimaz R, Cimino L, Gionchetti P, Girolomoni G, Lionetti P, Marcellusi A, Mennini FS, Salvarani C. - In: INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. - ISSN 0394-6320. - STAMPA. - 27:(2014), pp. 33-48. [10.1177/03946320140270S103]
Adalimumab in the treatment of immune-mediated diseases
CIMAZ, ROLANDO;LIONETTI, PAOLO;
2014
Abstract
Review showing the utility of Adalimumab (monoclonal antibody anti-TNF) in management of immune-mediated inflammatory diseases
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
